Tag: Alzheimer’s
-
Peer-Reviewed Studies Validate Linus Health AI as an Early Digital Biomarker for Alzheimer’s Pathology
Groundbreaking Findings Show AI Detects Alzheimer’s Pathology Earlier New peer-reviewed studies confirm that Linus Health’s artificial intelligence (AI) platform can indicate Alzheimer’s disease pathology before noticeable symptoms emerge. The research suggests that this early digital biomarker could empower patients, caregivers, and healthcare teams to take timely actions that may slow disease progression and preserve independence.…
-
Early Digital Biomarker: Linus Health AI Signals Alzheimer’s Pathology Before Symptoms
Groundbreaking Validation: Linus Health AI as an Early Digital Biomarker New peer‑reviewed studies validate Linus Health AI as a cutting-edge digital biomarker for Alzheimer’s pathology. The research suggests that the AI can indicate the presence of Alzheimer’s-related changes in the brain before noticeable cognitive symptoms arise, offering a window of opportunity for proactive intervention. By…
-
Dementia Daily Routines: Cut Anxiety and Calm Care at Home
Why routines matter when dementia changes daily life Dementia disrupts routines, and that disruption often leads to heightened anxiety for both the person living with dementia and their caregiver. Experts say that predictable, well-structured days offer essential grounding, reduce agitation, and improve overall well-being. The goal is not to erase memory loss but to create…
-
Astrocyte-Driven Reversal of Alzheimer’s Cognitive Decline: Mouse Study Sparks Hope
Groundbreaking Astrocyte Findings Point to a Natural Brain Cleanup Mechanism A recent study from Baylor College of Medicine highlights a promising, naturally occurring brain process that helps clear amyloid plaques and maintain cognitive function in mouse models of Alzheimer’s disease. The research focuses on astrocytes, star-shaped support cells in the brain, and how they can…
-
Astrocyte-Driven Therapy Shows Promise for Reversing Cognitive Decline in Alzheimer’s
New Astrocyte-Driven Mechanism Clears Amyloid Plaques and Preserves Cognition Scientists at Baylor College of Medicine have identified a natural, brain-immune process that can clear amyloid plaques and protect cognitive function in mouse models of Alzheimer’s disease. By harnessing the activity of astrocytes, a type of glial cell that supports and modulates neurons, researchers demonstrated a…
-
Astrocyte-Driven Approach Shows Promise in Reversing Cognitive Decline in Alzheimer’s
New Insights into Alzheimer’s: Astrocytes as Key Players In a compelling advance from Baylor College of Medicine, researchers have identified an astrocyte-driven mechanism that not only clears existing amyloid plaques in mouse models of Alzheimer’s disease but also preserves cognitive function. The study highlights a natural, brain-intrinsic process that can potentially counteract one of the…
-
Alzheimer’s Disease Hijacks Brain-Fat Communication and Metabolism
Overview: A new link between Alzheimer’s and metabolic health Alzheimer’s disease is widely known for its impact on memory and cognition, but a growing body of research is revealing deeper consequences for the body’s metabolic systems. A recent study from Houston Methodist highlights how Alzheimer’s disease may hijack the brain’s communication with fat tissue, a…
-
Nemours Neurologist Wins NIH Transformative Award to Study Hippocampal Dysfunction Across Autism, Epilepsy, and Alzheimer’s
Nemours neurologist wins prestigious NIH grant to study hippocampal dysfunction Rodney Scott, MBChB, MRCP, DipStat, PhD, Division Chief of Neurology at Nemours Children’s Health in the Delaware Valley, has been awarded a National Institutes of Health (NIH) Director’s Transformative Research Award. The $2.6 million, five-year grant will fund an ambitious project to investigate malfunctions in…
-
Nemours Neurologist Wins NIH Transformative Award to Study Hippocampal Dysfunction Across Brain Disorders
Nemours Leader Receives NIH Transformative Research Award Rodney Scott, MBChB, MRCP, DipStat, PhD, Division Chief of Neurology at Nemours Children’s Health in the Delaware Valley, has been awarded a prestigious NIH Director’s Transformative Research Award. The $2.6 million grant spans five years and targets a novel, cross-disciplinary approach to hippocampal dysfunction that may cut across…
-
Quitting Smoking in Middle Age Cuts Dementia Risk
What the study found A large, multi-country study involving 9,436 adults aged 40 and older from England, the United States and 10 other European countries found a striking cognitive benefit for those who quit smoking in middle age. Over a six-year follow-up period, quitters showed slower cognitive decline and a markedly better trajectory of memory…